Cosmo Pharmaceuticals NV banner

Intrinsic Value

The intrinsic value of Cosmo Pharmaceuticals NV (C43) under the Base Case is 60.66 EUR per share. Compared with the current market price of 58.4 EUR, the stock appears Undervalued by 4% .

The intrinsic value is the average of valuations using the DCF method and multiples.

Do our valuations actually work? See backtest results .

C43 Intrinsic Value
€60.66
Undervaluation 4%
Intrinsic Value
Price €58.4

We don’t have enough historical valuation data to make this comparison.

Alert me when C43 is below its intrinsic value
Today €48.53 · 16.9% below the current price
Alternatives to C43

Fundamental Analysis

What Cosmo Pharmaceuticals Does

Pharmaceuticals Health Care

Cosmo Pharmaceuticals is a specialty drug company focused on digestive health and endoscopy. It develops medicines and medical products used to treat gastrointestinal conditions and to help doctors inspect and treat the colon and other parts of the digestive tract. Its products are aimed mainly at hospitals, gastroenterologists, and sometimes pharmacies, depending on the product and market.

Headquarters
Ireland IE
Employees
325
IPO date
May 18, 2016
Read the full company overview
View Company Overview
Financials

Balance Sheet

Efficiency

Wall St Price Targets

Shareholder Returns

Competitive Landscape

Recent Events

Past 12 months

Continue C43 Research

Decided on Cosmo Pharmaceuticals? Get an email when C43 reaches the price you’d buy at. Free with an account.

Other Cosmo Pharmaceuticals listings

What is the Intrinsic Value of one C43 stock?

The intrinsic value for Cosmo Pharmaceuticals NV (C43) under the Base Case is 60.66 EUR.

Is C43 stock undervalued or overvalued?

Compared with the current market price of 58.4 EUR, the stock appears Undervalued by 4% .

How reliable are our estimates? See how past valuations played out
Back to Top